X hits on this document

PDF document

National Treatment Agency for Substance Misuse - page 49 / 52





49 / 52

34. Office of the Deputy Prime Minister/Home Office (2005) Housing Support Options For People Who Misuse Substances: Guidance for Supporting People Commissioners and Officers. London: HO, ODPM

35. Home Office/Office of the Deputy Prime Minister (2004) Providing for the Needs of Drug Interventions Programme Clients

36. This research is primarily from the DARP Project, run by the Institute of Behavioral Research at Texas Christian University. The main project report is Simpson D and Sells SB (1990) Opioid Addiction and Treatment: A 12-Year Follow-up. Florida, Robert E. Krieger

  • 37.

    A summary of DATOS research is available at www.datos.org

  • 38.

    Meier P (2005) A National Survey of Retention in Residential

Rehabilitation Services. London: NTA

39. Drug and Alcohol National Occupational Standards (DANOS) Skills for Health 2003. The full range of competences are available at www.skillsforhealth.org.uk/danos

40. Advisory Council on the Misuse of Drugs (2003) Hidden Harm: Responding to the Needs of Children of Problem Drug Users. The Report of an Inquiry by the Advisory Council on the Misuse of Drugs. London: Home Office

41. Department of Health (2004) The NHS Knowledge and Skills Framework (NHS KSF) and the Development Review Process (October 2004). London: DH

42. Department of Health (2002) Care Homes for Younger Adults and Adult Placements: Care Home Regulations, National Minimum Standards. London: DH

43. Substance Misuse Advisory Service (1999) Commissioning Standards for Drug and Alcohol Treatment. Substance Misuse Advisory Service

44. SCODA, Alcohol Concern (1999) Quality in Drugs and Alcohol Services (QuADS). London: SCODA, Alcohol Concern

45. Royal Pharmaceutical Society of Great Britain (latest edition) Medicines Ethics and Practice: A Guide for Pharmacists


Models of care for treatment of adult drug misusers: Update 2006

  • 46.

    UK Harm Reduction Alliance website at www.ukhra.org

  • 47.

    NTA (2006) Best Practice Guidance for Commissioners and

Providers for Pharmaceutical Services for Drug Users: Service Specification (Tier 2 or 3). London: NTA

  • 48.

    Chief Medical Officer’s Update Number 39, August 2004

  • 49.

    National Institute for Clinical Excellence (2000) Technology

Appraisal Guidance No. 14. Guidance on the Use of Ribavirin and Interferon Alpha for Hepatitis C. London: NICE

50. Department of Health (2001) Hepatitis C: Guidance for Those Working With Drug Users (London: DH)

51. National Treatment Agency (2004) Care Planning in Primary Care: Consensus Statement from the Primary Care Stakeholder Day. London: NTA

52. NTA (2005) Nurse Prescribing in Substance Misuse. London: NTA

53. Royal Pharmaceutical Society of Great Britain (2005) Clinical Governance Framework for Pharmacist Prescribers and Organisations Commissioning or Participating in Pharmacist Prescribing. London: RPSGB

54. Home Office (2005) Developing Peer Led Support For Individuals Leaving Substance Misuse Treatment. London: HO

55. Addaction (2005) Aftercare Consultation 2005: The Service User Perspective. London: Addaction

56. Stephenson M (2006) National Aftercare Research Project Year 3. London: Addaction

57. Home Office (2005) The 24/7 Client Single Point of Contact – Case Examples of Good Practice. London: Addaction

58. Home Office (2006) Promoting Practice between DAT Partnerships and Education Training and Employment Provision for Drug Interventions Programme Clients. London: Home Office

Document info
Document views87
Page views87
Page last viewedMon Oct 24 07:02:37 UTC 2016